$MGTX
MeiraGTx Holdings plc

2024 Q4 Form 10-Q Financial Statement

#000155837024015444 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $10.91M $5.103M
YoY Change 113.8% 5.96%
Cost Of Revenue $11.99M
YoY Change
Gross Profit -$1.075M
YoY Change
Gross Profit Margin -9.85%
Selling, General & Admin $24.71M $10.01M
YoY Change 146.83% -6.99%
% of Gross Profit
Research & Development $26.24M $27.86M
YoY Change -5.79% 65.2%
% of Gross Profit
Depreciation & Amortization $3.260M $3.480M
YoY Change -6.32% 71.6%
% of Gross Profit
Operating Expenses $50.95M $37.87M
YoY Change 34.56% 37.07%
Operating Profit -$40.04M -$32.76M
YoY Change 22.22% 43.64%
Interest Expense $3.357M $3.381M
YoY Change -0.71% 78.7%
% of Operating Profit
Other Income/Expense, Net -$49.00K -$40.00K
YoY Change 22.5% -46.67%
Pretax Income -$39.33M -$44.30M
YoY Change -11.22% 18.82%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$39.33M -$44.30M
YoY Change -11.21% 18.81%
Net Earnings / Revenue -360.49% -868.06%
Basic Earnings Per Share -$0.55 -$0.74
Diluted Earnings Per Share -$0.55 -$0.74
COMMON SHARES
Basic Shares Outstanding 78.15M 64.90M 59.54M
Diluted Shares Outstanding 71.63M 59.53M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $122.9M $63.40M
YoY Change 93.81% -44.73%
Cash & Equivalents $122.9M $63.37M
Short-Term Investments
Other Short-Term Assets $713.0K $758.0K
YoY Change -5.94% -51.44%
Inventory
Prepaid Expenses $7.029M $6.997M
Receivables $3.279M $22.40M
Other Receivables $5.152M $10.00M
Total Short-Term Assets $139.0M $103.5M
YoY Change 34.3% -33.22%
LONG-TERM ASSETS
Property, Plant & Equipment $112.5M $111.9M
YoY Change 0.59% 19.5%
Goodwill
YoY Change
Intangibles $951.0K $1.140M
YoY Change -16.58% -11.83%
Long-Term Investments $6.766M $6.326M
YoY Change 6.96% -4.96%
Other Assets $1.139M $1.421M
YoY Change -19.85% 7.49%
Total Long-Term Assets $160.4M $163.7M
YoY Change -1.97% 11.81%
TOTAL ASSETS
Total Short-Term Assets $139.0M $103.5M
Total Long-Term Assets $160.4M $163.7M
Total Assets $299.5M $267.2M
YoY Change 12.09% -11.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.50M $20.77M
YoY Change 42.03% -4.24%
Accrued Expenses $19.34M $28.25M
YoY Change -31.54% 14.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.42M $63.51M
YoY Change -6.45% -12.23%
LONG-TERM LIABILITIES
Long-Term Debt $72.94M $71.80M
YoY Change 1.59% 1.35%
Other Long-Term Liabilities $71.39M $39.80M
YoY Change 79.38% 12.55%
Total Long-Term Liabilities $144.3M $111.6M
YoY Change 29.33% 5.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.42M $63.51M
Total Long-Term Liabilities $144.3M $111.6M
Total Liabilities $203.8M $175.3M
YoY Change 16.23% -1.92%
SHAREHOLDERS EQUITY
Retained Earnings -$662.6M -$574.4M
YoY Change 15.36% 29.69%
Common Stock $3.000K $2.000K
YoY Change 50.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $95.74M $91.89M
YoY Change
Total Liabilities & Shareholders Equity $299.5M $267.2M
YoY Change 12.09% -11.35%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$39.33M -$44.30M
YoY Change -11.21% 18.81%
Depreciation, Depletion And Amortization $3.260M $3.480M
YoY Change -6.32% 71.6%
Cash From Operating Activities -$25.02M -$24.42M
YoY Change 2.47% 17.82%
INVESTING ACTIVITIES
Capital Expenditures $730.0K $3.560M
YoY Change -79.49% -135.56%
Acquisitions
YoY Change
Other Investing Activities -$584.0K
YoY Change
Cash From Investing Activities -$1.314M -$3.560M
YoY Change -63.09% -64.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.96M -410.0K
YoY Change -12284.63% -100.56%
NET CHANGE
Cash From Operating Activities -25.02M -24.42M
Cash From Investing Activities -1.314M -3.560M
Cash From Financing Activities 49.96M -410.0K
Net Change In Cash 23.62M -28.39M
YoY Change -183.2% -167.26%
FREE CASH FLOW
Cash From Operating Activities -$25.02M -$24.42M
Capital Expenditures $730.0K $3.560M
Free Cash Flow -$25.75M -$27.98M
YoY Change -7.96% 161.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.91
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71633150
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59526642
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66709847
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54544660
dei Entity Central Index Key
EntityCentralIndexKey
0001735438
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63601015
mgtx Excess Tax Benefit From Share Based Compensation Operating Activities1
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities1
0
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77695418
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
mgtx Operating Lease Number New Leases Recognized
OperatingLeaseNumberNewLeasesRecognized
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38520
dei Entity Registrant Name
EntityRegistrantName
MeiraGTx Holdings plc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1448305
dei Entity Address Address Line1
EntityAddressAddressLine1
450 East 29th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
14th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
860-7985
dei Security12b Title
Security12bTitle
Ordinary Shares,$0.00003881 par value per share
dei Trading Symbol
TradingSymbol
MGTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78153401
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122873000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129566000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3279000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10138000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7029000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5625000
CY2024Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
5152000
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
13277000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
713000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1016000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
139046000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
159622000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112541000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115896000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
951000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1118000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2156000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1083000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1139000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1917000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
6766000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6766000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12782000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15910000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24107000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24432000
CY2024Q3 us-gaap Assets
Assets
299488000
CY2023Q4 us-gaap Assets
Assets
326744000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
29504000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16042000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19341000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42639000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4183000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4193000
CY2024Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
5107000
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
2926000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1283000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1278000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
59418000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
67078000
CY2024Q3 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
58902000
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
34017000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9610000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12952000
CY2024Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2880000
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2401000
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
72942000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
72119000
CY2024Q3 us-gaap Liabilities
Liabilities
203752000
CY2023Q4 us-gaap Liabilities
Liabilities
188567000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00003881
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00003881
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1288327750
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1288327750
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77695418
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63601015
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
763204000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
693841000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4848000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1435000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-662623000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-554231000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
95736000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
138177000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
299488000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326744000
CY2024Q3 mgtx Service Revenue From Related Parties
ServiceRevenueFromRelatedParties
10910000
mgtx Service Revenue From Related Parties
ServiceRevenueFromRelatedParties
11889000
CY2023Q3 mgtx License Revenue From Related Parties
LicenseRevenueFromRelatedParties
5103000
mgtx License Revenue From Related Parties
LicenseRevenueFromRelatedParties
11977000
CY2024Q3 us-gaap Revenues
Revenues
10910000
CY2023Q3 us-gaap Revenues
Revenues
5103000
us-gaap Revenues
Revenues
11889000
us-gaap Revenues
Revenues
11977000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11985000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11985000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12723000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10009000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37127000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35169000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26243000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27856000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
95499000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70115000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
50951000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
37865000
us-gaap Operating Expenses
OperatingExpenses
144611000
us-gaap Operating Expenses
OperatingExpenses
105284000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-40041000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32762000
us-gaap Operating Income Loss
OperatingIncomeLoss
-132722000
us-gaap Operating Income Loss
OperatingIncomeLoss
-93307000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3463000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8677000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2644000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2915000
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1189000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
523000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3113000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1723000
CY2024Q3 us-gaap Interest Expense
InterestExpense
3357000
CY2023Q3 us-gaap Interest Expense
InterestExpense
3381000
us-gaap Interest Expense
InterestExpense
9861000
us-gaap Interest Expense
InterestExpense
9796000
CY2024Q3 mgtx Gain Loss On Sale Of Nonfinancial Assets
GainLossOnSaleOfNonfinancialAssets
-584000
mgtx Gain Loss On Sale Of Nonfinancial Assets
GainLossOnSaleOfNonfinancialAssets
28434000
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
53000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39330000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-44297000
us-gaap Net Income Loss
NetIncomeLoss
-108392000
us-gaap Net Income Loss
NetIncomeLoss
-104242000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1234000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6007000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3413000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1113000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40564000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38290000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-111805000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-103129000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39330000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44297000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-108392000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-104242000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71633150
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59526642
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66709847
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54544660
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
138177000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4739000
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1586000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
635000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1691000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-20442000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
121734000
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5810000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1612000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-488000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-48620000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
80039000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
937000
CY2024Q3 mgtx Issuance Of Shares In Connection With Registered Offering
IssuanceOfSharesInConnectionWithRegisteredOffering
50000000
CY2024Q3 mgtx Issuance Of Shares In Connection With Private Placement Offering
IssuanceOfSharesInConnectionWithPrivatePlacementOffering
1000000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1861000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6185000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1234000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-39330000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
95736000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
117738000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5201000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2353000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-30364000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
90222000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7271000
CY2023Q2 mgtx Issuance Of Shares In Connection With Private Placement Offering
IssuanceOfSharesInConnectionWithPrivatePlacementOffering
61950000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4003000
CY2023Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
209000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2541000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29581000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
123527000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6765000
CY2023Q3 mgtx Issuance Costs In Connection With Private Placement Offering
IssuanceCostsInConnectionWithPrivatePlacementOffering
116000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6007000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-44297000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
91886000
us-gaap Profit Loss
ProfitLoss
-108392000
us-gaap Profit Loss
ProfitLoss
-104242000
us-gaap Share Based Compensation
ShareBasedCompensation
19074000
us-gaap Share Based Compensation
ShareBasedCompensation
20756000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2644000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2915000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9757000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9818000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-158000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-153000
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
418000
us-gaap Disposal Group Not Discontinued Operation Loss Gain On Write Down
DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
89000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
146000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
130000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
824000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
809000
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
53000
mgtx Gain Loss On Sale Of Nonfinancial Assets
GainLossOnSaleOfNonfinancialAssets
28434000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-5033000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
198000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1289000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1212000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-8170000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2283000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-923000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-898000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-689000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
15000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14024000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5393000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-23350000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13917000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
123000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
23867000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11977000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81219000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90818000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3737000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17144000
mgtx Proceeds From Gain On Sale Of Nonfinancial Assets
ProceedsFromGainOnSaleOfNonfinancialAssets
28434000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24697000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17144000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2340000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1519000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
55135000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
61950000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2505000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4119000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50290000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56312000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6232000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-51650000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
612000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
537000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130649000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115516000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125029000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64403000
us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
1897000
us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
2941000
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
370000
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
209000
us-gaap Interest Paid Net
InterestPaidNet
8864000
us-gaap Interest Paid Net
InterestPaidNet
9965000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-662600000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81200000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 24.45pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 24.45pt;">Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. This process may result in actual results differing materially from those estimated amounts used in the preparation of the financial statements if these results differ from historical experience, or other assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made. In preparing these condensed consolidated financial statements, management used significant estimates in the following areas, among others: collaboration and service revenue, fair value of nonfinancial assets, stand-alone selling price and material rights in connection with the Asset Purchase and Supply Agreements, the accounting for research and development costs, share-based compensation, leases, asset retirement obligations, fair value of financial instruments and tax incentive receivable.</p>
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122873000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129566000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2156000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1083000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125029000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130649000
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2401000
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2179000
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
370000
mgtx Asset Retirement Obligations Amortization Of Interest
AssetRetirementObligationsAmortizationOfInterest
146000
mgtx Asset Retirement Obligations Amortization Of Interest
AssetRetirementObligationsAmortizationOfInterest
130000
us-gaap Asset Retirement Obligation Foreign Currency Translation Gain Loss
AssetRetirementObligationForeignCurrencyTranslationGainLoss
-37000
us-gaap Asset Retirement Obligation Foreign Currency Translation Gain Loss
AssetRetirementObligationForeignCurrencyTranslationGainLoss
10000
CY2024Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2880000
CY2023Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2319000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13498020
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11867971
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
150381000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
157356000
CY2024Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
6766000
CY2024Q3 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
6665000
CY2024Q3 mgtx Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
5652000
CY2023Q4 mgtx Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
8713000
CY2024Q3 mgtx Accrued Research And Development
AccruedResearchAndDevelopment
3841000
CY2023Q4 mgtx Accrued Research And Development
AccruedResearchAndDevelopment
5834000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3031000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6499000
CY2024Q3 mgtx Accrued Liabilities Accrued Manufacturing Costs Expense
AccruedLiabilitiesAccruedManufacturingCostsExpense
1993000
CY2023Q4 mgtx Accrued Liabilities Accrued Manufacturing Costs Expense
AccruedLiabilitiesAccruedManufacturingCostsExpense
2634000
CY2024Q3 mgtx Accrued Liabilities Accrued Compensation And Benefits
AccruedLiabilitiesAccruedCompensationAndBenefits
1712000
CY2023Q4 mgtx Accrued Liabilities Accrued Compensation And Benefits
AccruedLiabilitiesAccruedCompensationAndBenefits
12129000
CY2024Q3 mgtx Accrued Consulting Expenses
AccruedConsultingExpenses
1258000
CY2023Q4 mgtx Accrued Consulting Expenses
AccruedConsultingExpenses
2104000
CY2024Q3 mgtx Accrued Expenses Incurred In Connection With Fixed Assets
AccruedExpensesIncurredInConnectionWithFixedAssets
1194000
CY2023Q4 mgtx Accrued Expenses Incurred In Connection With Fixed Assets
AccruedExpensesIncurredInConnectionWithFixedAssets
1472000
CY2024Q3 mgtx Accrued Expenses Incurred In Connection With Rent And Facility Costs
AccruedExpensesIncurredInConnectionWithRentAndFacilityCosts
180000
CY2023Q4 mgtx Accrued Expenses Incurred In Connection With Rent And Facility Costs
AccruedExpensesIncurredInConnectionWithRentAndFacilityCosts
142000
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
2936000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
480000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
176000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19341000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42639000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8226707
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.96
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
365100
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
318537
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.69
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8273270
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M4D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6673069
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8273270
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y8M4D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
526
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
526
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2300000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2800000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.67
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6304000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7053000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19074000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20756000
mgtx Excess Tax Benefit From Share Based Compensation Operating Activities1
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities1
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
mgtx Gain Loss On Sale Of Nonfinancial Assets
GainLossOnSaleOfNonfinancialAssets
28400000
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1400000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4300000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4100000
mgtx Operating Lease Number New Leases Recognized
OperatingLeaseNumberNewLeasesRecognized
0
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
218000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
274000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
218000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
274000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1428000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1371000
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
74000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
40000
CY2024Q3 us-gaap Lease Cost
LeaseCost
1720000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1685000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
778000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
838000
us-gaap Variable Lease Cost
VariableLeaseCost
778000
us-gaap Variable Lease Cost
VariableLeaseCost
838000
us-gaap Operating Lease Cost
OperatingLeaseCost
4300000
us-gaap Operating Lease Cost
OperatingLeaseCost
4103000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
162000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
119000
us-gaap Lease Cost
LeaseCost
5240000
us-gaap Lease Cost
LeaseCost
5060000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12782000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15910000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13793000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17145000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24107000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
24432000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P174Y1M6D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P174Y9M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.088
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.088
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1329000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1407000
us-gaap Operating Lease Payments
OperatingLeasePayments
4180000
us-gaap Operating Lease Payments
OperatingLeasePayments
4233000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1309000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5359000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5548000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1624000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1400000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
735000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15975000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2182000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
13793000
CY2024Q3 mgtx Number Of New Material Commitments
NumberOfNewMaterialCommitments
0

Files In Submission

Name View Source Status
0001558370-24-015444-index-headers.html Edgar Link pending
0001558370-24-015444-index.html Edgar Link pending
0001558370-24-015444.txt Edgar Link pending
0001558370-24-015444-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mgtx-20240930.xsd Edgar Link pending
mgtx-20240930x10q.htm Edgar Link pending
mgtx-20240930xex31d1.htm Edgar Link pending
mgtx-20240930xex31d2.htm Edgar Link pending
mgtx-20240930xex32d1.htm Edgar Link pending
mgtx-20240930xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mgtx-20240930_cal.xml Edgar Link unprocessable
mgtx-20240930_def.xml Edgar Link unprocessable
mgtx-20240930_lab.xml Edgar Link unprocessable
mgtx-20240930_pre.xml Edgar Link unprocessable
mgtx-20240930x10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending